Dr Adlinda Binti Alip

Dr Adlinda graduated from Southampton University, UK and completed general medical training before being awarded the MRCP by the Royal College of Physician, UK. She obtained FRCR by the Royal College of Radiologist (Clinical Oncology) UK and awarded a certificate of completion (CCT) in Clinical Oncology by General Medical Council UK in 2011. She joined the University of Malaya as a Senior Lecturer and Clinical Oncologist in 2012. She is a principal and sub-investigator for several ongoing and completed clinical trials. She gives talks and presentation locally and in international meetings. Her main areas of interest include Lung, Breast, Genitourinary and Stereotactic Radiosurgery/Radiotherapy.

MD.Elżbieta Senkus

  Elżbieta Senkus is a senior lecturer at the Department of Oncology and Radiotherapy   Elżbieta Senkus is a senior lecturer at the Department of Oncology and Radiotherapy, Medical University of Gdańsk, Poland. She graduated from the Medical University of Gdańsk in 1991 (diploma cum laude) and finished training in radiation oncology in 1998 and in medical oncology in 2004. In 1995 she obtained a PhD on brachytherapy of cervical cancer. Her main scientific interest in breast cancer is molecular basis of disease in high-risk patients. She is the Faculty Member for the Breast Cancer of the European Society for Medical Oncology (ESMO) and European School of Oncology (ESO). She is also involved in developing international guidelines for early and metastatic breast cancer as the Section Editor of the ESMO Guidelines Committee. Elżbieta Senkus is actively involved in clinical research, including national and international academic and industry-sponsored programs. She has coordinated 2 national phase III studies and currently is responsible for coordinating some international programs on a national basis. Elżbieta Senkus serves as a Specialty Editor for the „The Breast” journal and has been actively involved in undergraduate and postgraduate teaching, including courses organized by the European Society for Therapeutic Radiology and Oncology (ESTRO), ESMO and ESO. Elżbieta Senkus-Konefka is a member of ESMO, the European Society of Breast Cancer Specialists (EUSOMA) and of the Mensa International. Since 2013 she has been a member of the Steering Committee of the EORTC Breast Cancer Group (BCG), of which she is now the Secretary-Elect. She has contributed to over 100 peer-reviewed publications, fifteen book chapters and was an editor of a textbook. Cumulated impact factor of publications: 427; 2479 citations, h-score 21 (Scopus database, viewed Sep. 17, 2017). She has two sons of 22 and 20. Her hobbies include traveling, horse-back riding, skiing and designing jewellery.

BICHAY, Tewfik Jermyn

Tewfik J. Bichay, Ph.D.

Dr. Bichay obtained his B.Sc. degree in Physiology from McGill University, Montreal, his M.Sc. in Biology from Concordia University, Montreal, and his Ph.D. in Medical Biophysics from the University of Western Ontario, London, Canada. He is currently Director of Medical Physics, Radiation Oncology, the Lacks Cancer Center at Mercy Health, St. Mary’s, Grand Rapids, MI. He started his career as a radiation biologist before transitioning into medical physicist with a residency at the Ottawa Regional Cancer Center. He is an accreditation surveyor for the ACR, served for a number of years as an ABR MOC examination committee member, and is the previous President of the Great Lakes Chapter of the AAPM, and holds a patent on a compact doorless radiation vault design. He is certified in Radiation Oncology Physics by the ABMP and his present research interests include SRS and SBRT.

Anna Wrona, MD PhD

Anna Wrona, MD PhD,

Department of Oncology and Radiotherapy, Medical University of Gdansk


Consultant of radiation oncology and academic in one of the most exhilarating Polish cancer centers – in the Department of Oncology and Radiotherapy of Medical University of Gdańsk.


  • European Thoracic Oncology Platform(ETOP)
  • European Organization for Research and Treatment of Cancer(EORTC).


  • Polish Society of Oncology (PTO),
  • European Society for Radiotherapy and Oncology(ESTRO)
  • International Association for the Study of Lung Cancer (IASLC).
  • Associate editor of Journal Club column in Nowotwory Journal. 

Area of interest:

  • Thoracic oncology.
  • Cancer molecular biology and resistance mechanisms.


  • ESMO 2017.
  • Polish Congress of Medical Oncology
  • Conference of Polish Lung Cancer Group
  • World Conference on Lung Cancer.

Prof. Dr. Hamdy Abdel Azim

Founder, Cairocure

Current Positions and Titles

Chairman of Kasr Al-Ainy School Of Oncology (KASO), official Cancer education organization, Department of Oncology, Faculty of Medicine, Cairo University. Professor of Clinical Oncology, Faculty of Medicine, Cairo University, Cairo, Egypt President of Africa Middle East Cancer Research Inter group. Referee for the Annals of Oncology Journal, THE BREAST, The Breast Journal (TBJ), BMC Cancer, Chemotherapy journal , Advances in Cancer Research & Treatment , Journal of the Egyptian National Cancer Institute, and the Chinese Clinical Oncology Journal. Pioneering Activity

Past chairman of the Oncology Department, Faculty of Medicine, Cairo University. First to represent the Middle East countries on the ASCO international committee, for a period of 5 years ( May 1997-May 2002) Chief editor of 2 educational books ASCO PANARAB Lymphoma Conference (1999) and the MD Anderson Cancer Centre / Cairo University joint meeting (2006) More than 80 scientific and research publications. Scientist of the Year from the International Biographical Centre, Cambridge, UK (2002) The Order of Merit,Cambridge University (2002) The Best Arab Oncologist from the Lebanese Society of Medical Oncology (LSMO,2004) The recognition award for significant contribution to the Oncology field in the middle east from UAE (Dubai -2013) Dr Azim signed the Charter of Paris against Cancer on behalf of the Arab World in February 2000.

Bouthaina S. Dabaja, M.D

Dr. Bouthaina Dabaja received her Medical Doctorate at the Lebanese University. She completed her clinical residencies at the American University of Beirut and The University of Texas MD Anderson Cancer Center. She began her career at MD Anderson following her residency in 2006 and has progressed from Assistant Professor to Professor and Section Chief of the Hematology Section in Radiation Oncology. Her primary clinical goal is patient care with an emphasis on maintaining and improving cure rate in patients with lymphoma while decreasing the short and long term side effects of treatment. She is extensively involved in clinical trials to investigate multiple strategies to deliver better treatment options for lymphoma patients with the goal of minimizing long term side effects on patients treated for mediastinal lymphomas which remains a great clinical challenge.

Professor Dirk Arnold

Associate Professor, Department of Radiation Oncology,

ESMO Board Member

Dirk Arnold is Director of the Dept. Medical Oncology at Klinik für Tumorbiologie, Freiburg, Germany. Before taking this position, he was 2010 appointed as Director of the University Cancer Centre in Hamburg (UCCH) and held positions at the University Departments for Oncology and Haematology in Halle-Wittenberg and Berlin. His major field of scientific interest are gastrointestinal cancers, and here specifically modern therapeutic approaches in biomarker-driven decision processes, and multimodal treatment strategies, also including other specialities. Here, he serves as chairman of Colorectal Cancer Study Group of the German AIO, a major collaborative group in clinical oncology. Within the AIO framework, he served as founding member of the Central Clinical Trials Office, underlining his expertise also in methodology of clinical research. Furthermore, his interest is the organisation of larger collaborative research structures and of integrated cancer centre networks. Prof. Arnold is also member of the American Society of Clinical Oncology and Task Force Member of the National Cancer Institute, as well as Board member of the EORTC GI study group. Furthermore, he is board member of the German Society of Haematology and Medical Oncology (DGHO), and member of the German Cancer Society. Within ESMO, since 2012 he is section editor for GI cancers in the Guidelines Committee and Associate Editor with .

Dr.Stefan Rauh

Consultant of Clinical Radiotherapy and Assistant Professor

Centre Hospitalier Emile Mayrisch (CHEM) Luxembourg Dr Stefan Rauh works as a medical oncologist/haematologist at the Centre Hospitalier Emile Mayrisch (CHEM), Differdange and Esch in Luxembourg. Born 1964 in Munich, Germany, he studied Medicine in Munich and Lausanne, Switzerland, followed by post-graduate training in Munich, Nancy, France and Luxembourg. In 1999, he was given the opportunity to develop an oncology unit (including out-patient hospital and palliative unit) at Differdange Regional Hospital. In 2010 the hospital merged with Esch, making a total of 500 beds. He is now part of the CHEM oncology unit with palliative care and President of CHEM’s Plateform Cancer. His work is mainly clinical, however his work also includes teaching and clinical research activity and he is interested in co-operations with developing countries. At present, he serves as a tutor and lecturer at the General Medicine Faculty of the University of Luxembourg. He is currently involved in eight international clinical phase 3 and 4 studies, and has developed prospective randomised studies in out patient symptom monitoring in Luxembourg (pro-elects). Studies involve the CRP Santé, CIEC and IBBL, some are in collaboration with the CHL. Dr Rauh is Vice President of the Société Luxembourgeoise d’Oncology and a member of the National Tumor Registry’s board, the National Plan Cancer, the Luxembourg National Cancer Center Project and of the Scientific Council of the National Social Security. Dr Rauh is a qualified member of ESMO and served as the National Representative for Luxembourg for eight years. From 2015, he is the Chair of the ESMO Practising Oncologists Working Group and has a seat on the ESMO Executive Board. In addition, he is an extended member of the ESMO Public Policy Working Group. He is also a member of ASCO, ASH and a volunteer of Health Volunteers Overseas.  


تهران.هتل المپیک





عضویت در خبرنامه